NDC 0641-6173-01 - Dicyclomine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6173
- Requested NDC
- 0641-6173-01
- Package NDCs from labels
- 0641-6173-01, 0641-6173-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dicyclomine Hydrochloride - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6173-01 | Dicyclomine Hydrochloride | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | 6 | |
| 0641-6173-10 | Dicyclomine Hydrochloride | 10 in 1 CARTON | INJECTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6173-01 | ML - Milliliter | 0641-6173 | ab15b7e1-d21f-4c4b-8c68-2f96570bca38 | 1 | 2016-04-04 |
| 0641-6173-10 | ML - Milliliter | 0641-6173 | 165bccf2-7ebb-4747-b9ae-cc32f2a1916a | 1 | 2016-04-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Bryant Ranch Prepack | b3b8ee01-ec7c-4b17-a237-59ba45cdf3f9 | 2023-10-26 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Solco Healthcare US,LLC | d0954a7a-812b-487e-8c22-2a2a58303277 | 2023-07-28 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Golden State Medical Supply, Inc. | 01413a77-48f8-1a8a-e063-6394a90ae494 | 2023-07-24 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Proficient Rx LP | 346bbb6a-3499-4e90-af22-95f1cd0c0417 | 2023-07-01 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 99d7d1ce-47b5-4bbd-afe0-908505a9a51b | 2023-06-05 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Aurobindo Pharma Limited | ec746016-eed0-4e37-bb9c-cb430c8a7f07 | 2023-05-19 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Aurobindo Pharma Limited | d81b93f8-bebc-455e-82b6-9a3de3f82e92 | 2023-05-04 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | A-S Medication Solutions | 5f5d7145-118b-4cab-bfe0-19f7740ef1fe | 2023-02-04 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | aa5bd79d-7f18-4032-8862-0c5429b2ecaf | 2023-01-31 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Proficient Rx LP | bd8b7fcd-04f4-4d1c-aa27-743aaf4c2876 | 2022-03-01 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine | DICYCLOMINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 5a553bda-1e3d-4b80-913f-73dd54655033 | 2021-11-30 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Novitium Pharma LLC | b0911994-0b36-439d-8247-5d885a899421 | 2021-04-23 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | American Regent, Inc. | cab4ecaf-8895-4ae8-add3-233d9cc570a8 | 2021-03-01 | Warnings, Adverse reactions | 991065 CQ903KQA31 |
| DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HYDROCHLORIDE | Fosun Pharma USA Inc. | cbc22f25-e100-4c59-8f38-5f82113166fb | 2019-10-19 | Warnings, Adverse reactions | 991065 CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 860e8ea6-6f9b-4fe6-a23d-3600b69c0b35 | 2019-04-29 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | da2c43f8-1c3a-447f-8994-f9899fb5e141 | 2018-12-20 | Warnings, Adverse reactions | CQ903KQA31 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.